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Abstract
Background—Regular adherence to mammography screening saves lives yet few women receive
regular mammograms.
Design—RCT.
Setting/participants—Participants were recruited through a state employee health plan. All were
women aged 40–75 years and had recent mammograms prior to enrollment (n=3,547). Data were
collected from 2004 to 2009.
Intervention—The efficacy was tested of a two-step adaptively designed intervention to increase
mammography adherence over 4 years. The first intervention step consisted of three reminder types:
enhanced usual care reminders (EUCR), enhanced letter reminders (ELR), both delivered by mail,
and automated telephone reminders (ATR). After delivery of reminders, women who became off-
schedule in any of the 4 years received a second step of supplemental interventions. Three
supplemental intervention arms contained priming letters and telephone counseling: barriers only
(BarriCall), barriers plus positive consequences of getting mammograms (BarriConCall+), and
barriers plus negative consequences of not getting mammograms (BarriConCall−).
Main outcome measures—Average cumulative number of days non-adherent to mammography
over 4 years based on annual screening guidelines (analyses conducted in 2009)
Results—All reminders performed equally well in reducing number of days of non-adherence.
Women randomized to receive supplemental interventions had significantly fewer days of non-
adherence compared to women who received EUCR (p=0.0003). BarrConCall+ and BarrConCall−
conditions did not significantly differ in days non-adherent compared to women in the barriers-only
condition (BarriCon).
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Conclusions—The minimal intervention needed for sustained mammography use is a combination
of a reminder followed by a priming letter and barrier-specific telephone counseling for women who
become off-schedule. Additional costs associated with supplemental interventions should be
considered by organizations deciding which interventions to use.
Introduction
Each year, more than 192,000 U.S. women are diagnosed, and about 40,170 women die from
breast cancer.1 Numerous studies have shown that regular mammography use among women
aged ≥40 years and reduces breast cancer morbidity and mortality.2–5 Increased rates of annual
screening could reduce mortality by 22% each year.6 Although there have been impressive
gains in proportions of U.S. women receiving recent mammograms, less than 50% of women
receive two consecutive screening mammograms at recommended intervals.7 After more than
1 decade of rising rates, some evidence suggests that mammography rates are no longer
increasing in the U.S.8 Thus, adherence to mammography among U.S. women remains a
concern.
Until recently, most mammography interventions focused on encouraging short-term
adherence (e.g., over 1–2 years). This was appropriate when mammography was at an earlier
stage in the diffusion cycle; the primary challenge then was to move women from never having
had mammograms to having their first mammograms or to move lapsed screeners back on
schedule.9 Now that most U.S. women have had one or more mammograms, the appropriate
focus should be on sustained adherence over time. Most mammography intervention trials
assessed outcomes across only one or two screening mammograms.10–14 Efficacy of
mammography promotion interventions over time is not known.
Relatively simple patient-directed strategies, such as reminders, are effective for increasing
mammography adherence.15–25 More-intensive patient-directed strategies (e.g., tailored
messages, telephone counseling) are more effective than usual care or less-intensive strategies.
15, 17, 20, 24–28 Intensive intervention strategies, however, are more costly to develop,
implement, and sustain15, 29, 30 and may be beneficial for only some women. Many women
may respond to minimal interventions that cue them to have their mammograms on schedule.
Adaptively designed interventions may be an effective strategy to promote sustained
mammography adherence and to evaluate the “minimal intervention necessary for
change” (MINC).31 In adaptive designs, individuals receive different interventions or doses
based on their responses to earlier interventions.32 Few mammography intervention trials have
used adaptive designs.13, 33–36 Results of prior adaptively designed trials have been mixed but
most found that more-intensive strategies, such as telephone counseling, outperformed less-
intensive strategies and facilitated a return to adherence.33–35 However, no trials were designed
to sustain annual-interval adherence in average-risk, insured women aged ≥40 years. Moreover,
none were designed to provide direct comparisons among various types of minimal and more-
intensive intervention strategies over multiple screening opportunities.
Rationale for Study Design
Personally Relevant Information on Screening Mammography (PRISM) was designed to test
effects of two-step adaptively designed interventions to increase sustained mammography
adherence. PRISM began with the least intensive evidence-based interventions, reserving
more-intensive interventions for those who needed them. After delivery of one of three minimal
reminder interventions, women who became non-adherent in any of the study's 4 years received
more-intensive supplemental interventions. Depending on study condition, some women
received additional content that elaborated on positive consequences of receiving or negative
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consequences of skipping regular mammograms. PRISM sought to answer the following
research questions.
1. Which reminder type is most effective for reducing days' non-adherent to
mammography screening over 4 years?
2. To what extent do supplemental interventions reduce the number of days of non-
adherence to mammography screening over 4 years compared to reminders only?
3. Which supplemental intervention is most effective for reducing the number of days
non-adherent to mammography screening over 4 years?
Methods
Study Participants and Recruitment
Study eligibility and recruitment are described elsewhere.37 Briefly, PRISM participants were
identified through the North Carolina State Health Plan for Teachers and State Employees
(SHP). Eligible women were residents of North Carolina, aged 40 to 75 years, had no personal
history of breast cancer, and had recent mammograms (8 to 9 months before enrollment).
Recruitment occurred between October 2004 and April 2005. Participants (n=3547) completed
30-minute baseline telephone interviews and agreed to participate in interventions and follow-
up interviews over 4 years. IRBs for the University of North Carolina and Duke University
approved this research.
Study Objective and Design
Study Objective and Design—The primary study objective was to identify minimal
intervention needed for sustained mammography adherence over 4 years. PRISM was a two-
step adaptively designed intervention (Figure 1). The two-step process resulted in nine
intervention strategies into which participants were randomized (Table 1). The first
intervention step consisted of yearly mammography reminders. After delivery of reminders,
women who became off-schedule in any of the 4 years received a second step of supplemental
interventions.
In the first step, women received one of three reminders: enhanced usual care reminders
(EUCRs), enhanced letter reminders (ELRs), and automated telephone reminders (ATRs).
Twenty-five percent of eligible participants were allocated to EUCR, 37.5% to ATR and 37.5%
to the ELR so that sample sizes would be sufficient for assessing efficacy of supplemental
interventions. PRISM did not include a non-intervention control. Since multiple studies have
shown that reminders are effective for promoting mammography use compared to non-
intervention controls;15 study investigators and the SHP concluded that it would be unethical
to include a non-intervention group. Thus, a usual care reminder was created since none existed
at the time of the study and it was referred to as enhanced, because it was more detailed than
many minimal reminders.
All supplemental interventions consisted of priming letters (tailored letters which prepared
women for counseling calls) and telephone counseling to address women's barriers to
mammography adherence. In addition to a supplemental intervention condition that focused
on barriers only (BarriCall), other supplemental intervention conditions emphasized positive
consequences of having (BarriConCall+) or negative consequences of not having regular
mammograms (BarriConCall−) to determine whether these additions improved adherence over
barriers alone. Only women in the ATR and ELR groups could receive supplemental
interventions. This design enabled assessment of the incremental impact of supplemental
interventions compared to usual care reminders (EUCR). Inclusion of a supplemental
intervention control arm that received only PRISM reminders (ATR/ELR only) permitted a
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comparison of the efficacy of different supplemental intervention arms. Equal proportions of
women were allocated to BarriCall (25%), BarriConCall+ (25%), BarriConCall− (25%) and
PRISM reminder (25%) groups.
PRISM Interventions
Theoretic Orientation—Because maintenance of repeated, infrequent behaviors, such as
mammography, is likely controlled by deliberative reasoning processes and past experiences,
this project integrated constructs from several predominant theories of health behavior and
strategies for behavior enaction. Key constructs and strategies come from the Health Belief
Model,38 Theory of Planned Behavior,39 Model of Goal-Directed Behavior,40 and the
Elaboration Likelihood Model.41
Both the Health Belief Model and Theory of Planned Behavior identify factors that motivate
behavior change, such as risk perceptions, disease susceptibility and severity, self-efficacy,
intentions, and assessments of barriers and benefits to engaging in a behavior. Model of Goal-
Directed Behavior focuses on strategies that translate motivation to action, differentiating
habitual behaviors, like getting regular exercise, from those performed infrequently. Model of
Goal-Directed Behavior strategies include elaboration on positive consequences of engaging
in and negative consequences of not engaging in a behavior. Elaboration Likelihood Model
focuses on the role of information processing on attitude and behavior change, postulating that
interventions motivating deep information processing are more likely to result in sustainable
attitude and behavior changes.
Reminders—Details of PRISM reminders are provided elsewhere.37 Briefly, EUCRs were
printed letters reminding women they were due for their next mammograms. ELRs were printed
booklets similar in content to EUCRs but contained several additions (e.g., reminder stickers,
theory-guided information). ATRs contained identical content to EUCRs but were delivered
as automated telephone messages using a female voice. All provided information about when
women were due for their next mammograms and motivational messages to encourage them
to be screened.
Supplemental interventions
Tailoring: Supplemental interventions consisted of tailored priming letters and telephone
counseling. Intervention materials were tailored to individual women by converting raw data
from interviews into calculated variables that reflected characteristics of interest (e.g., women's
mammography barriers).42, 43 Tailoring algorithms determined which message each woman
received from a message library. Women who reported no barriers or did not complete recent
follow-up interviews received default messages.
Priming Letters: Priming letters primed or prepared women for subsequent telephone
counseling calls. They were four-page printed booklets with cover art of colorful quilts and
contained four sections: (1) text reminding women that they were overdue for their next
mammograms; (2) tailored messages about overcoming barriers to mammography based on
participants' self-reported barriers at annual telephone interviews; (3) narrative that addressed
key barriers selected by researchers (BarriCall) plus a focus on either the positive consequences
of getting (BarriConCall+) or the negative consequences (BarriConCall−) of not getting regular
mammograms; and (4) text reminding women of screening mammography guidelines and
telephone information for the health plan, NCI's Cancer Information Service (1-800-4-
CANCER), and text informing women they would receive a call from a PRISM telephone
counselor.
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Priming letters addressed up to four barriers. On average, women reported two barriers (range
0–11). Barriers related to forgetting to make/keep mammography appointment, being too busy,
or having competing problems or priorities (e.g., family or personal illness) were the most
common.
Priming letters were pretested for content and appearance with a volunteer group of SHP
members who were not part of PRISM. The priming letters' appearance, tailoring algorithms,
and content was varied slightly each year so that they would not be identical to previous PLs,
but the content was largely the same. Priming letters were developed in collaboration with
People Designs Inc. of Durham, NC. People Designs printed priming letters each week based
on weekly data transfers received from PRISM researchers. Study staff reviewed PLs' accuracy
prior to delivery.
Telephone Counseling: The goal of telephone counseling calls was to review and facilitate
elaboration on priming letter content and assist women in overcoming their mammography-
related barriers. Each counseling call was unique, based on each woman's needs, but structured,
based on a computer-assisted telephone counseling program developed in an earlier study and
revised for this one.12, 44 Calls started with brief introduction and confirmation of previous
mammography dates. Counselors then asked women what was getting in the way of obtaining
their next mammograms and suggested ways to overcome these barriers. Counselors repeated
the process until women offered no additional barriers to screening. Barriers related to being
too busy, difficulty scheduling appointment, competing priorities, and cost of mammography
were the most common ones addressed during telephone counseling.
Depending on study condition, counselors also encouraged elaboration on either the positive
(BarriConCall+) or negative (BarriConCall−) consequences of getting or skipping regular
mammograms. Finally, counselors summarized key points of the session and helped women
make a plan to be screened soon. Telephone counseling content was pretested with a volunteer
group of women SHP members who were not part of PRISM.
Women who confirmed they had not received their mammograms at the time of calls received
full counseling consisting of all components described above (mean 13.20 minutes; range 3.07–
33.49). Women who had recent mammograms but were off-schedule received modified
counseling in which counselors asked women to think about what delayed their mammograms,
helped them get mammograms, and could have helped them be screened sooner. Modified
counseling ended with a reminder of when they were due for their next mammograms (mean
5.20 minutes; range 2.01–15.50).
Telephone counselors participated in an intensive training program that included education
about screening mammography and motivational interviewing techniques,45 mock calls using
the computer-assisted telephone counseling program, and weekly ongoing training. Training
was led by PhD-level clinical psychologists and health educators. Quality assurance was
conducted for ∼10% of telephone counseling calls and addressed issues as needed with
counselors.
Intervention Delivery—Researchers received monthly mammography claims information
to determine women's adherence status and intervention delivery. Delivery of reminders
occurred 2 to 3 months prior to women's mammography due dates. Women overdue for annual
screening were sent mailed priming letters about 3 months past participants' due dates.
Telephone counseling call attempts began 10 days later. Delivery of subsequent interventions
over the 4-year study was timed from participants' most recent mammograms. Thus,
participants continued to receive yearly mammography reminders 2–3 months before they were
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due for their next mammograms, based on an annual screening recommendation,46 followed
by supplemental interventions if they became overdue in any year.
Study Interviews
Participants completed 30-minute baseline telephone interviews during study recruitment and
consent. Baseline interviews included questions about sociodemographics, mammography
history, general health information, and mammography-specific psychosocial correlates.
Telephone interviewers recontacted women at 12, 24, 36, and 42 months post–baseline survey.
Nonparticipation in any follow-up interview did not preclude women from being contacted for
subsequent interviews. The interviews at 12, 24, and 36 months were similar to baseline
interviews; interviews at 42 months were abbreviated for budgetary reasons and included only
items assessing outcomes and major variables of interest. Data were collected from 2004 to
2009.
Interviewers asked women to confirm dates of their most recent and prior mammograms, based
on claims data. Women who reported a breast cancer diagnosis (n=63) received abbreviated
interviews but did not continue to receive interventions. Women who withdrew from the study
were not contacted for follow-up interviews (n=128). Recommended procedures were used for
study retention, including multiple call attempts during participants' requested days/times of
the week, small study incentives (postage stamps), and thank you letters.
Measures
Outcome
The outcome, mammography non-adherence, was defined as the cumulative number of days
non-adherent for each woman during the 4-year study period. Women became non-adherent
when 365 days had elapsed since their last screening. This outcome was based on American
Cancer Society recommendations at the time of the study which suggested women aged ≥40
years should have mammograms annually. Mammograms occurring within 6 months of the
previous one were likely diagnostic or follow-up visits and removed from outcome calculation.
47 Once non-adherent, a calculated variable counted number of days until receipt of a
subsequent mammogram. That is, each day beyond 365 contributed 1 day of non-adherence;
counting ceased when women received subsequent mammograms but resumed again if women
did not receive their next mammograms within 365 days. Values for cumulative days of non-
adherence could range from 0 to 1,098.
The outcome was assessed through self-report and health claims data. Women who completed
follow-up interviews were asked to confirm dates of both their recent and prior mammograms
obtained from claims data. If a discrepancy between self-report and claims data occurred, self-
reports were used, because it often took several months for mammograms to appear in claims
records. Previous research confirms that self-reports are valid measures of recent
mammography use, especially for women in healthcare organizations and over short recall
periods.48, 49
Independent Variables
Independent variables were based on intervention strategies.
Costs
Costs of PRISM interventions were estimated assuming fully scaled dissemination within a
large health organization. Intervention costs included production expenses (e.g., postage,
printing, envelopes) and personnel time spent producing and delivering interventions and
supervising and training staff. Estimates excluded research and development costs that would
Gierisch et al. Page 6













not be incurred during replication and an indirect cost level of 50% was assumed for facilities
and infrastructure costs. For telephone counseling, an average call length of 13 minutes was
assumed with 10 call attempts per completed call.
Sample Size
Power analyses indicated a target sample size of about 3545 participants to achieve 80% power
to detect a 6% difference in effect among intervention arms, with alpha of 0.05 and two-tailed
tests. Sample size was adjusted for estimated attrition over the 4-year study as well as multiple
testing in comparisons of study groups. This sample size was sufficient to detect potentially
small effects between study groups. The adherence level was higher than expected; thus, fewer
participants received supplemental interventions.
Data Analysis
Analyses were intent-to-treat and included all women randomized to interventions except those
diagnosed with breast cancer (n=63) and women who died during the study (n=29). The final
analytic sample included 3455 participants. For study withdrawals (n=128), mammography
dates were imputed based on the average length of time between mammograms prior to leaving
the study.
Bootstrapping procedures were used with case resampling to assess differences in mean
number of days' non-adherent among intervention strategies.50 Bootstrapping procedures
adjusted for multiple comparisons. In brief, bootstrapping is a nonparametric procedure that
does not assume normal distribution of data. Bootstrapping procedures resampled data 10,000
times and computed p-values for each sample. From those sample p-values, an adjusted p-
value was calculated.
To assess intervention efficiency, it was first examined whether there were any significant
differences in cumulative number of days non-adherent for women randomized to each of the
study reminder conditions. Next, it was checked whether there were significant differences in
cumulative days non-adherent for women randomized to receive EUCR compared to
supplemental interventions and among supplemental interventions. Analyses were conducted
in 2009 using the MULTTEST procedure in SAS 9.2 statistical software.
Results
Sample characteristics
Sample characteristics are reported in Table 2. Most were white, aged ≥50 years, college-
educated, married or living as married, did not report financial hardship, and described their
health as good or excellent. Women who withdrew (n=128) did not differ significantly by study
condition or sociodemographic characteristics.
Intervention Efficacy
To determine which reminder type was most effective for reducing days non-adherent
(Research Question 1), average days non-adherent were compared among reminder-only
conditions (that is, among women not randomized to receive any supplemental interventions).
Differences in mean days non-adherent over the study were not significant among reminder
conditions and ranged from 15.73 to 24.13 days (Table 3).
To determine the extent to which supplemental interventions reduced days non-adherent
beyond reminders only (Research Question 2), average days non-adherent were compared
among women randomized to receive EUCRs to women randomized to receive any of the three
supplemental intervention conditions (BarriCall, BarriConCall+, BarriConCall−). Women
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randomized to receive any form of supplemental intervention had significantly fewer mean
days non-adherent (183.40) than women receiving EUCRs only (221.95; p-value=0.0003).
Absolute difference in mean days non-adherent for these groups was 38.55.
It was then examined which supplemental intervention strategy was most effective in reducing
days non-adherent (Research Question 3). Because there were no significant differences among
the three reminder conditions (Research Question 1), collapsed supplemental conditions were
collapsed into three groups (BarriCall, BarriConCall+, BarriConCall−). First, the BarriConCall
+ and BarriConCall− conditions were compared. Finding no significant differences, these
conditions were collapsed into one group (BarriConCall+/−). The EUCR were then compared
to two types of supplemental intervention conditions (BarriCall and BarriConCall+/−). Both
types of supplemental interventions significantly reduced average days non-adherent compared
to EUCR (mean differences 39.56 and 38.05 days respectively; p-values 0.0042 and 0.0008
respectively). BarriCall and BarriConCall+/− conditions performed equally well in reducing
days non-adherent (p-value=0.98) (Table 4).
Cost Analyses—Previously, the cost of reminder conditions per intended recipient was
reported as $0.86 for EUCR, $0.35 for ATR, and $1.34 for ELR.37 A universal cost was
estimated for supplemental interventions (priming letters + telephone counseling), regardless
of study condition; cost of delivery was not affected by study condition. Assuming delivery to
500,000 women per year, the estimated cost per intended recipient is $2.76 for priming letters
and $16.65 for telephone counseling. Total cost of delivering the complete supplemental
intervention one time to one woman is estimated at $19.41.
Discussion
To our knowledge, PRISM is the first adaptively designed intervention study to assess a
combination of minimal and more-intensive strategies on sustained mammography adherence
over multiple screening opportunities. Results indicate that reminders followed by priming
letters and barriers-specific telephone counseling for women who became off-schedule
produced the fewest cumulative days non-adherent. Differences among study conditions were
modest; inclusion of any supplemental interventions increased cost per dose by $19.41.
This study supports previous literature showing effectiveness of simple mammography
reminders15 and extends these finding to longer-term outcomes. On average, when women
received reminders alone, there were averages of 198 to 222 days non-adherent per woman
over the 4-year study. These numbers translate to an average of about 50 to 60 days non-
adherent per woman-year of the study, suggesting that most women in PRISM received regular,
on-schedule mammograms after delivery of reminders. However, since PRISM did not include
a no-intervention control group, it is not possible to determine how much of these effects are
due to reminder efficacy. While all reminder types were equally effective, ATRs cost less to
deliver than printed materials.37 Many health plans and other medical organizations already
use automated telephone reminders over traditional mailed reminders as a less costly but
equally effective option for promoting regular mammography. Other organizations may want
to consider this approach.
Providing supplemental interventions facilitated a return to adherence among women who were
off-schedule. Women randomized to receive priming letters and telephone counseling, in
addition to reminders, had fewer average days non-adherent compared to women who received
EUCR. Many studies support telephone counseling as an effective strategy to promote
mammography adherence.12, 15, 29, 51, 52 PRISM extends these findings in several ways. First,
results showed that addition of a more-intensive, tailored counseling component for women
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who became off-schedule was an effective strategy to reduce days non-adherent over
multiple years. Past studies on telephone counseling focused on short-term outcomes.12, 52
Results also indicate that telephone counseling addressing women's barriers to getting
mammograms may be the minimal component necessary for tailored counseling calls. While
this finding suggests that enhancements to the barriers strategy did not add value, it is also
plausible that if the consequences interventions had been stronger or designed differently, there
might have been greater effects. Alternatively, barriers may account for the largest variation
in non-adherence. Once barriers are addressed, the incremental benefit of adding additional
counseling components may be small. Given current attention to issues of comparative
effectiveness, understanding when additional intervention components add value and when
they do not is critical to improving the U.S. healthcare system.
While overall differences in average days non-adherent between intervention groups were
modest, it is likely that study effects would have been greater if there had not been a usual care
condition enhanced with information (e.g., mammography guidelines, insurance coverage
information). At the time of the study, the State Health Plan did not have a mammography
reminder system. The PRISM-enhanced usual care reminder likely contained information
beyond what many reminder systems typically use and could have attenuated differences
between groups.
Findings also should be viewed in the context of long-term screening behavior. Modest savings
in days non-adherent for the study period may add up over potential decades of regular
screening, depending on the durability of intervention effects over time. While supplemental
interventions contributed to 39 fewer days non-adherent over the 4-year study compared to
EUCRs, this would translate to nearly 200 days of avoided non-adherence over 2 decades of
screening and to nearly 300 days over 3 decades of screening. Some studies suggest that even
relatively short delays of 6–12 months between screenings might contribute to some of the
nation's breast cancer morbidity and mortality.53–55 Intervention strategies that result in modest
savings in screening delays may have larger impacts on breast cancer mortality over time.
However, it still is not clear just how many days would make a clinical difference. There will
not be one answer since this is a multifactorial issue.
This study has several strengths, including an adaptive design which allowed the allocation of
more-intensive and costly interventions for only those women most likely to benefit, based on
their adherence status. Other study strengths include use of mammography claims data verified
through self-reports to determine adherence, which likely enhanced accuracy of calculating
mammography use.
This study also has some limitations. PRISM's design required that all women have health
insurance coverage and recent mammograms prior to study entry. Results should not be
generalized beyond these groups. Overall, women were well-educated, and numbers of black
women and other racial and ethnic minorities were modest. Most likely, this was a function of
eligibility criteria, but it is not possible to be certain. Assuring external validity with regard to
more diverse socioeconomic and racial/ethnic backgrounds should be a focus of future
research.
While the incremental benefit of supplemental interventions added to a reminder system were
assessed, the design does not permit the disentangling of effects of mailed priming letters from
telephone counseling calls. These two strategies were implemented as a complementary,
bundled intervention. Adding only supplemental mailed mammography promotion materials
to a reminder system may not be an effective strategy to facilitate a return to adherence.13, 33,
34 In contrast, other studies support telephone counseling as a stand alone strategy to promote
Gierisch et al. Page 9













mammography adherence.56, 57 It is reasonable to consider that telephone counseling alone
would have added benefit beyond annual reminders.
Interventions were designed with potential dissemination in mind and conducted the study with
a defined population of health plan members. While it is hypothesized that findings would be
similar if disseminated within an entire health plan, future effectiveness trials should test this
assumption with both adherent and non-adherent women. It is plausible that having been
screened recently, coupled with participating in a 4-year study with annual study interviews,
may have motivated some women to have mammograms.58 Future studies should assess
intervention reach, implementation, and effectiveness in non-research settings.59, 60
While it appears that the minimal intervention needed for sustained mammography use is a
combination of a reminder followed by a priming letter and barrier-specific telephone
counseling for women who become off-schedule, additional costs associated with
supplemental interventions ($19.41 per dose) should be considered by any organization
deciding which interventions to use. Although it was not possible in the current study to
evaluate cost effectiveness of supplemental interventions, such cost analyses should be a core
component in future research.
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Figure 1. PRISM study design
a Random allocation to study arms occurred prior to participant contact and recruitment. Larger
numbers for ATR and ELR were planned for analysis of supplemental interventions. Equal
proportions of participants were allocated to supplemental interventions.
b Supplemental intervention for non-adherent women in any year.
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Table 1
PRISM study intervention strategies
Reminder intervention Supplemental interventions Study condition n (%)
Reminder-only conditions
Enhanced usual care reminder None EUCR 823 (23.8)
Automated telephone reminder None ATR 318 (9.2)
Enhanced letter reminder None ELR 337 (9.8)
Supplemental intervention conditions
Automated telephone reminder Barriers-only priming letter and telephone counseling ATR + BarriCall 338 (9.8)
Automated telephone reminder
Barriers + positive consequences priming letter and telephone
counseling ATR + BarriConCall+ 335 (9.7)
Automated telephone reminder
Barriers + negative consequences priming letter and telephone
counseling ATR + BarriConCall− 328 (9.5)
Enhanced letter reminder Barriers-only priming letter and telephone counseling ELR + BarriCall 318 (9.2)
Enhanced letter reminder
Barriers + positive consequences priming letter and telephone
counseling ELR + BarriConCall+ 327 (9.5)
Enhanced letter reminder
Barriers + negative consequences priming letter and telephone
counseling ELR + BarriConCall− 331 (9.6)
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Table 3
Comparison of reminder strategies
Study condition comparisons n
Days non-adherent
(M [SD]) Difference in days p-value
ELR and EUCR 24.13 0.20
 Enhanced letter reminder 337 197.82 (234.57)
 Enhanced usual care reminder 823 221.95 (258.38)
ATR and EUCR 15.73 0.51
 Automated telephone reminder 318 206.22 (244.05)
 Enhanced usual care reminder 823 221.95 (258.38)













Gierisch et al. Page 19
Table 4
Comparison of supplemental strategies
Study condition comparisons n
Days non-adherent
(M [SD]) Difference in days p-value
Supplemental interventions and EUCR 38.55 0.0003
 Any supplemental intervention 1977 183.40 (217.35)
 Enhanced usual care reminder 823 221.95 (258.38)
BarriConCall + and BarriConCall − 5.38 0.9661
 BarriConCall + 662 181.22 (209.11)
 BarriConCall − 659 186.60 (221.68)
BarriCall and EUCR 39.56 0.0042
 Barriers-only priming letter and telephone counseling 656 182.39 (221.37)
 Enhanced usual care reminder 823 221.95 (258.38)
BarriConCall +/− and EUCR 38.05 0.0008
 Barriers plus positive/negative consequences priming letter and telephone
counseling 1321 183.90 (215.40)
 Enhanced usual care reminder 823 221.95 (258.38)
BarriConCall (+/−) and BarriCall 1.51 0.9871
 Barriers plus positive/negative consequences priming letter and telephone
counseling 1321 183.90 (215.40)
 Barriers-only priming letter and telephone counseling 656 182.39 (221.37)
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